TGF‐β1 potentiates astrocytic nitric oxide production by expanding the population of astrocytes that express NOS‐2
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Both transforming growth factor‐β1 (TGF‐β1) and nitric oxide synthase‐2 (NOS‐2) are upregulated under various neuropathological states. Evidence suggests that TGF‐β1 can either attenuate or augment NOS‐2 expression, with the prevailing effect dependent on the experimental paradigm employed and the cell‐type under study. The purpose of the present study was to determine the effect of TGF‐β1 on astrocytic NOS‐2 expression. In purified astrocyte cultures, TGF‐β1 alone did not induce NOS‐2 or NO production. However, NO production induced by lipopolysaccharide (LPS) plus IFNγ was enhanced by TGF‐β1 in a concentration‐dependent manner between 10 and 1,000 pg/mL. The presence of IFNγ was not necessary for this effect to occur, as TGF‐β1 enhanced NO production induced by LPS in a similar fashion. In cultures stimulated with LPS plus IFNγ, the enhancement of NO production by TGF‐β1 was associated with a corresponding increase in NOS‐2 mRNA and protein expression. Interestingly, immunocytochemical assessment of NOS‐2 protein expression demonstrated that TGF‐β1 augmented astrocytic NO production, specifically by increasing the pool of astrocytes capable of expressing NOS‐2 induced by either LPS (∼threefold) or LPS plus IFNγ (∼sevenfold). In a broader sense, our results suggest that TGF‐β1 recruits a latent population of astrocytes to respond to stimulation by pro‐inflammatory mediators. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei, S. Z., Chen, H.-S. V., Sucher, N. J., Loscalzo, J., Singel, D. J., & Stamler, J. S. (1993) · Nature · doi:10.1038/364626a0 · Cited by 2,433 · cited 1×
“In addition, high concentrations of NO can actually reduce NMDA receptor-dependent neuronal cell death by decreasing channel activity (Lipton et al., 1993; Vidwans et al., 1999).”
BackgroundNew roles for astrocytes: redefining the functional architecture of the brain.
Nedergaard, M., Ransom, B., & Goldman, S. A. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.008 · Cited by 1,334 · cited 1×
“…demonstrate that astrocytic NOS-2-derived NO contributes to neuronal cell death (Chao et al., 1996; Hewett et al., 1994, 1996; Hu et al., 1997; Okuno et al., 2005; Vidwans and Grant sponsor: NINDS, National Institutes of Health; Grant number: NS36812; Grant sponsor: American Heart Association.”
BackgroundLiberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 3×
“The bulk of experimental evidence indicates that NOS-2 contributes to neurological injury (Iadecola et al., 1995b, 1997; Liberatore et al., 1999; Pozza et al., 2000; Shin et al., 1998, 2000; Smith and Lassmann, 2002), perhaps leading one to conclude that any increase in NOS-2 expression, and hence…”
BackgroundBal-Price, A., & Brown, G. C. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06480.2001 · Cited by 686
Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease
Wyss-Coray, T., Masliah, E., Mallory, M., McConlogue, L., Johnson-Wood, K., Lin, C., & Mucke, L. (1997) · Nature · doi:10.1038/39321 · Cited by 417 · cited 3×
“…and neuroprotective (Buisson et al., 2003; Dhandapani and Brann, 2003; Flanders et al., 1998; Kim et al., 2004), several studies reveal a pro-inflammatory role for TGF-b1 in the brain (Burton et al., 2002; Grammas and Ovase, 2002; Lesne et al., 2003; Wyss-Coray et al., 1995, 1997a,1997b).”
BackgroundTRANSFORMING GROWTH FACTOR-βS IN NEURODEGENERATIVE DISEASE
FLANDERS, K. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00066-x · Cited by 364
Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Dewachter, I., Walter, J., Klockgether, T., & Van Leuven, F. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-22 · Cited by 309 · cited 2×
“marked astrocytic NOS-2 immunoreactivity (Heneka et al., 2005; Pozner et al., 2005; Tran et al., 1997; Wallace and Bisland, 1994).”
An Antiviral Mechanism of Nitric Oxide
Saura, M., Zaragoza, C., McMillan, A., Quick, R. A., Hohenadl, C., Lowenstein, J. M., & Lowenstein, C. J. (1999) · Immunity · doi:10.1016/s1074-7613(00)80003-5 · Cited by 245 · cited 1×
“For example, the cytostatic and/or cytotoxic effects of high levels of NO are beneficial during bacterial or viral infection (Leib et al., 1998; Lowenstein and Padalko, 2004; MacMicking et al., 1997; Saura et al., 1999; Saxena et al., 2001).”
BackgroundNathan, C., Calingasan, N., Nezezon, J., Ding, A., Lucia, M. S., La Perle, K., Fuortes, M., Lin, M., Ehrt, S., Kwon, N. S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051529 · Cited by 214 · cited 1×
“This includes maintenance of neuronal homeostasis, formation and preservation of the blood brain barrier, and participation in brain energy metabolism (Hansson and Ronnback, 1990; Nedergaard et al., 2003).”
BackgroundLüth, H.-J., Holzer, M., Gärtner, U., Staufenbiel, M., & Arendt, T. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02758-5 · Cited by 183 · cited 2×
“…by inflammatory mediators in several neurological diseases/disorders, including cerebral ischemia, Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis (Iadecola et al., 1995a; Katsuse et al., 2003; Komori et al., 1998; Luth et al., 2001; Sasaki et al., 2000; Smith and Lassmann, 2002).”
BackgroundHypoxia modulates nitric oxide-induced regulation of NMDA receptor currents and neuronal cell death
Gbadegesin, M., Vicini, S., Hewett, S. J., Wink, D. A., Espey, M., Pluta, R. M., & Colton, C. A. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.4.c673 · Cited by 47
Self-citation
Cited by
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
“2b) to gain of detrimental effects such as (1) exacerbating inflammation via cytokine production [22, 23], (2) producing neurotoxic levels of reactive oxygen species [92, 234], (3) releasing potentially excitotoxic glutamate [238], (4) potential contribution to seizure genesis [106, 240], (5) compromising blood brain…”
BackgroundMolecular dissection of reactive astrogliosis and glial scar formation
Sofroniew, M. V. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.08.002 · Cited by 2,594
Astrocyte heterogeneity: an underappreciated topic in neurobiology
Zhang, Y., & Barres, B. A. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.06.005 · Cited by 552
Neuroinflammation in the central nervous system: Symphony of glial cells
Yang, Q., & Zhou, J. (2019) · Glia · doi:10.1002/glia.23571 · Cited by 519
Reactive Astrocytes As Therapeutic Targets for CNS Disorders
Hamby, M. E., & Sofroniew, M. V. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.003 · Cited by 365
Self-citation
Metadata
- Authors
- Hamby, M. E., Hewett, J. A., & Hewett, S. J.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2006-08-18
- Volume
- 54
- Issue
- 6
- Pages
- 566-577
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2108301498
- Cited by
- 72
- References
- 11
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.